Literature DB >> 26114249

Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2-deoxy-glucose affects effector functions.

Kathrin Renner1,2, Anna-Lena Geiselhöringer1,2, Matthias Fante1, Christina Bruss1, Stephanie Färber1,2, Gabriele Schönhammer1,2, Katrin Peter1, Katrin Singer1, Reinhard Andreesen1,2, Petra Hoffmann1,2, Peter Oefner3, Wolfgang Herr1,2, Marina Kreutz1,2.   

Abstract

The strong link between T-cell metabolism and effector functions is well characterized in the murine system but hardly investigated in human T cells. Therefore, we analyzed glycolytic and mitochondrial activity in correlation to function in activated human CD4 and CD8 T cells. Glycolysis was barely detectable upon stimulation but accelerated beyond 24 h, whereas mitochondrial activity was elevated immediately in both T-cell populations. Glucose deprivation or mitochondrial restriction reduced proliferation, had only a transient impact on "on-blast formation" and no impact on viability, IFN-γ, IL-2, IL-4, and IL-10 production, whereas TNF was reduced. Similar results were obtained in bulk T cells and T-cell subsets. Elevated respiration under glucose restriction demonstrated metabolic flexibility. Administration of the glycolytic inhibitor 2-deoxy-glucose suppressed both glycolysis and respiration and exerted a strong impact on cytokine production that persisted for IFN-γ after removal of 2-deoxy-glucose. Taken together, glycolytic or mitochondrial restriction alone compromised proliferation of human T cells, but barely affected their effector functions. In contrast, effector functions were severely affected by 2-deoxy-glucose treatment.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  2-deoxy-glucose; ATP; Cytokines; Glucose deprivation; Human CD4 T cells; Human CD8 T cells; Metabolism; Mitochondrial inhibition

Mesh:

Substances:

Year:  2015        PMID: 26114249     DOI: 10.1002/eji.201545473

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  30 in total

Review 1.  Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.

Authors:  Katrina E Allison; Brenda L Coomber; Byram W Bridle
Journal:  Immunology       Date:  2017-07-10       Impact factor: 7.397

Review 2.  Learning from clinical trials of neoadjuvant checkpoint blockade.

Authors:  Judith M Versluis; Georgina V Long; Christian U Blank
Journal:  Nat Med       Date:  2020-04-09       Impact factor: 53.440

3.  PI3K-Akt signaling controls PFKFB3 expression during human T-lymphocyte activation.

Authors:  Helga Simon-Molas; Claudia Arnedo-Pac; Pere Fontova; Anna Vidal-Alabró; Esther Castaño; Ana Rodríguez-García; Àurea Navarro-Sabaté; Núria Lloberas; Anna Manzano; Ramon Bartrons
Journal:  Mol Cell Biochem       Date:  2018-02-12       Impact factor: 3.396

Review 4.  Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.

Authors:  Kristin G Anderson; Ingunn M Stromnes; Philip D Greenberg
Journal:  Cancer Cell       Date:  2017-03-13       Impact factor: 31.743

Review 5.  Obesity altered T cell metabolism and the response to infection.

Authors:  William D Green; Melinda A Beck
Journal:  Curr Opin Immunol       Date:  2017-03-27       Impact factor: 7.486

6.  Effect of HIV infection and antiretroviral therapy on immune cellular functions.

Authors:  Marek Korencak; Morgan Byrne; Enrico Richter; Bruce T Schultz; Patrick Juszczak; Julie A Ake; Anuradha Ganesan; Jason F Okulicz; Merlin L Robb; Buena de Los Reyes; Sandra Winning; Joachim Fandrey; Timothy H Burgess; Stefan Esser; Nelson L Michael; Brian K Agan; Hendrik Streeck
Journal:  JCI Insight       Date:  2019-06-20

7.  Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8+ T cells.

Authors:  Lelisa F Gemta; Peter J Siska; Marin E Nelson; Xia Gao; Xiaojing Liu; Jason W Locasale; Hideo Yagita; Craig L Slingluff; Kyle L Hoehn; Jeffrey C Rathmell; Timothy N J Bullock
Journal:  Sci Immunol       Date:  2019-01-25

Review 8.  Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Authors:  Julieta Afonso; Lúcio L Santos; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  Nat Rev Urol       Date:  2020-01-17       Impact factor: 14.432

9.  Increased Mitochondrial Biogenesis and Reactive Oxygen Species Production Accompany Prolonged CD4+ T Cell Activation.

Authors:  Billur Akkaya; Alexander S Roesler; Pietro Miozzo; Brandon P Theall; Jafar Al Souz; Margery G Smelkinson; Juraj Kabat; Javier Traba; Michael N Sack; Joseph A Brzostowski; Mirna Pena; David W Dorward; Susan K Pierce; Munir Akkaya
Journal:  J Immunol       Date:  2018-10-29       Impact factor: 5.422

Review 10.  Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism.

Authors:  Ilaria Elia; Marcia C Haigis
Journal:  Nat Metab       Date:  2021-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.